Literature DB >> 15659663

Characterization of a truncated lipoarabinomannan from the Actinomycete Turicella otitidis.

Martine Gilleron1, Natalie J Garton, Jérôme Nigou, Thérèse Brando, Germain Puzo, Iain C Sutcliffe.   

Abstract

Lipoarabinomannan (LAM) lipoglycans have been characterized from a range of mycolic acid-containing actinomycetes and from the amycolate actinomycete Amycolatopsis sulphurea. To further understand the structural diversity of this family, we have characterized the lipoglycan of the otic commensal Turicella otitidis. T. otitidis LAM (TotLAM) has been determined to consist of a mannosyl phosphatidylinositol anchor unit carrying an (alpha 1-->6)-linked mannan core and substituted with terminal-arabinosyl branches. Thus, TotLAM has a novel truncated LAM structure. Using the human monocytic THP-1 cell line, it was found that TotLAM exhibited only minimal ability to induce tumor necrosis factor alpha. These findings contribute further to our understanding of actinomycete LAM diversity and allow further speculation as to the correlation between LAM structure and the immunomodulatory activities of these lipoglycans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659663      PMCID: PMC545729          DOI: 10.1128/JB.187.3.854-861.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  50 in total

Review 1.  Atypical lipoteichoic acids of gram-positive bacteria.

Authors:  I C Sutcliffe; N Shaw
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

2.  Possible existence of a novel amphipathic immunostimulator in the phenol-water extracts of Mycobacteriaceae.

Authors:  T Ikeda-Fujita; S Kotani; M Tsujimoto; T Ogawa; I Takahashi; H Takada; H Shimauchi; S Nagao; S Kokeguchi; K Kato
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

3.  Molecular analysis of the lipoglycans of Mycobacterium tuberculosis.

Authors:  K Leopold; W Fischer
Journal:  Anal Biochem       Date:  1993-01       Impact factor: 3.365

4.  Spheroplast formation and plasmid isolation from Rhodococcus spp.

Authors:  N A Assaf; W A Dick
Journal:  Biotechniques       Date:  1993-12       Impact factor: 1.993

5.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins.

Authors:  D Marion; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1983-06-29       Impact factor: 3.575

6.  Erythrocyte binding properties of streptococcal lipoteichoic acids.

Authors:  E H Beachey; J B Dale; W A Simpson; J D Evans; K W Knox; I Ofek; A J Wicken
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Miniaturization of three carbohydrate analyses using a microsample plate reader.

Authors:  J D Fox; J F Robyt
Journal:  Anal Biochem       Date:  1991-05-15       Impact factor: 3.365

8.  Coryneform bacteria isolated from middle ear fluid.

Authors:  M Simonet; D De Briel; I Boucot; R Minck; M Veron
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

Review 9.  Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.

Authors:  Volker Briken; Steven A Porcelli; Gurdyal S Besra; Laurent Kremer
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

10.  Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry.

Authors:  A Venisse; J M Berjeaud; P Chaurand; M Gilleron; G Puzo
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  7 in total

1.  The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface.

Authors:  Sylvain Pitarque; Gérald Larrouy-Maumus; Bruno Payré; Mary Jackson; Germain Puzo; Jérôme Nigou
Journal:  Tuberculosis (Edinb)       Date:  2008-06-09       Impact factor: 3.131

2.  Macroamphiphilic components of thermophilic actinomycetes: identification of lipoteichoic acid in Thermobifida fusca.

Authors:  Obaidur Rahman; Markus Pfitzenmaier; Oxana Pester; Siegfried Morath; Stephen P Cummings; Thomas Hartung; Iain C Sutcliffe
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

3.  Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities.

Authors:  Marlène Cot; Aurélie Ray; Martine Gilleron; Alain Vercellone; Gérald Larrouy-Maumus; Elise Armau; Sophie Gauthier; Gérard Tiraby; Germain Puzo; Jérôme Nigou
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

Review 4.  Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan.

Authors:  Isabelle Vergne; Martine Gilleron; Jérôme Nigou
Journal:  Front Cell Infect Microbiol       Date:  2015-01-12       Impact factor: 5.293

Review 5.  Surfactants tailored by the class Actinobacteria.

Authors:  Johannes H Kügler; Marilize Le Roes-Hill; Christoph Syldatk; Rudolf Hausmann
Journal:  Front Microbiol       Date:  2015-03-19       Impact factor: 5.640

6.  Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.

Authors:  Masanori Kawasaki; Carmenchu Echiverri; Lawrence Raymond; Elizabeth Cadena; Evelyn Reside; Maria Tarcela Gler; Tetsuya Oda; Ryuta Ito; Ryo Higashiyama; Kiyonori Katsuragi; Yongge Liu
Journal:  PLoS Med       Date:  2019-04-12       Impact factor: 11.069

7.  Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2.

Authors:  Alexiane Decout; Sandro Silva-Gomes; Daniel Drocourt; Emilyne Blattes; Michel Rivière; Jacques Prandi; Gérald Larrouy-Maumus; Anne-Marie Caminade; Beston Hamasur; Gunilla Källenius; Devinder Kaur; Karen M Dobos; Megan Lucas; Iain C Sutcliffe; Gurdyal S Besra; Ben J Appelmelk; Martine Gilleron; Mary Jackson; Alain Vercellone; Gérard Tiraby; Jérôme Nigou
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.